Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 4/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | XIAP | P98170 | 1/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30466149 | 1.00 | SLC1A1 (0.52) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL10591983 | 1.00 | SLC1A1 (0.52) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL10994023 | 1.00 | SLC1A1 (0.52) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL7754254 | 1.00 | SLC1A1 (0.52) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL4161005 | 0.95 | IDO1 (0.53) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL10441465 | 0.95 | IDO1 (0.53) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL3471267 | 0.93 | SLC1A1 (0.55) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL28361329 | 0.93 | SLC1A1 (0.55) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| Hydrochloric Acid SCHEMBL28986973 | 0.93 | IDO1 (0.52) | SLC1A1SLC1A3ALPIPKMPTGS1 | |
| SCHEMBL5618771 | 0.93 | SLC1A1 (0.55) | SLC1A1SLC1A3ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243472-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-07-31 | — | — | US | claimed |
| CN-118986933-A | Nanometer preparation for delivering medicine on demand aiming at inherent barrier of pancreatic cancer, and preparation method and application thereof | 复旦大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118903052-A | Stimulus response type nanocapsule for delivering PROTAC, preparation method and application | 复旦大学 | 2024-11-08 | — | — | CN | claimed |
| CN-118459755-B | Gemcitabine nano prodrug with stable circulation and preparation method and application thereof | 复旦大学 | 2024-10-11 | — | — | CN | claimed |
| CN-116509801-B | Hypoxia response drug delivery micelle adapting to pancreatic cancer microenvironment and preparation method thereof | 复旦大学 | 2024-07-05 | — | — | CN | claimed |
| CN-118256603-A | Modified enzymes | 牛津纳米孔科技公开有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-116509801-A | Hypoxia response drug delivery micelle adapting to pancreatic cancer microenvironment and preparation method thereof | 复旦大学 | 2023-08-01 | — | — | CN | claimed |
| CN-108912324-A | A kind of inner membrance is the polyester peptide vesica and the preparation method and application thereof of positive electricity | 苏州大学 | 2018-11-30 | — | — | CN | claimed |
| US-20150166786-A1 | POLY((LACTIC-CO-GLYCOLIC ACID)-B-LYSINE) AND PROCESS FOR SYNTHESIZING A BLOCK COPOLYMER OF PLGA AND PLL (POLY-E-CBZ-L-LYSINE) | InVivo Therapeutics Corp. (US) | 2015-06-18 | — | — | US | claimed |
| US-8735093-B2 | Mutant pyrrolysyl-tRNA synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same | RIKEN (JP) | 2014-05-27 | — | — | US | claimed |
| EP-2046733-B1 | PROCESS FOR THE PREPARATION OF EPSILON-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES | ITALIANA SINT SPA (IT) | 2011-10-05 | — | — | EP | claimed |
| US-7968519-B2 | Amido-containing metal complexes; sonication; for self-assembling polypeptides; vesicles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-28 | — | — | US | claimed |
| US-20080125581-A1 | Methods and compositions for controlled polypeptide synthesis | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2008-05-29 | — | — | US | claimed |
| EP-0709373-B1 | PYRROLIDINE DERIVATIVE | ZAIDAN HOJIN BISEIBUTSU (JP) | 2001-10-17 | — | — | EP | claimed |
| US-4842924-A | HIGH COMPRESSIVE, TENSILE STRENGTH | FARRIS RICHARD J (US) | 1989-06-27 | — | — | US | claimed |
| JP-62270619-A | — | — | None | — | — | JP | disclosed |
| CN-122029203-A | Novel enzymes | 牛津纳米孔科技公开有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-4578219-A | CONTRACEPTIVE VACCINE | NORTHWESTERN UNIVERSITY (US) | 1986-03-25 | — | — | US | disclosed |
| EP-0154343-A2 | Adsorbent | Research Development Corporation of Japan (JP) | 1985-09-11 | — | — | EP | disclosed |
| US-4033940-A | TERMINAL CYSTINE, REARRANGEMENT TO CYCLIC DISULFIDE | ARMOUR PHARMACEUTICAL COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125581-A1 | Methods and compositions for controlled polypeptide synthesis | NGLY1, LNPEP, NPPA | SLC1A1 313/4885SLC1A3 266/4885ALPI 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.